Jana Care
Series B in 2023
Jana Care, Inc. is a company focused on developing mobile diagnostic solutions for the screening, management, and monitoring of chronic diseases. Its flagship products include The Aina Device, a self-monitoring tool for patients, and The Aina Station, a diagnostic solution for clinics and hospitals. These devices facilitate a range of tests, such as blood glucose, HbA1c, lipid profiles, creatinine, and hemoglobin. Additionally, Jana Care offers The Habits Program, a twelve-week digital coaching initiative aimed at managing diabetes and pre-diabetes. Founded in 2011 and headquartered in Boston, Massachusetts, with an additional office in Bengaluru, India, Jana Care was inspired by a challenge from a physician-entrepreneur to create innovative health solutions for remote communities in India, ultimately evolving into one of the largest chronic disease screening programs globally.
MediBuddy
Venture Round in 2023
MediBuddy is a digital healthcare platform designed to provide seamless access to a variety of healthcare services, including online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, regardless of time or location. The platform enables patients to consult with specialist doctors through calls or chat, share medical reports, and receive online consultations and prescriptions. With the capability to offer medical support within half an hour's notice, MediBuddy leverages technology to effectively connect patients with healthcare providers, thereby bridging the gap in healthcare accessibility.
MediBuddy
Series C in 2022
MediBuddy is a digital healthcare platform designed to provide seamless access to a variety of healthcare services, including online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, regardless of time or location. The platform enables patients to consult with specialist doctors through calls or chat, share medical reports, and receive online consultations and prescriptions. With the capability to offer medical support within half an hour's notice, MediBuddy leverages technology to effectively connect patients with healthcare providers, thereby bridging the gap in healthcare accessibility.
MediBuddy
Series B in 2021
MediBuddy is a digital healthcare platform designed to provide seamless access to a variety of healthcare services, including online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, regardless of time or location. The platform enables patients to consult with specialist doctors through calls or chat, share medical reports, and receive online consultations and prescriptions. With the capability to offer medical support within half an hour's notice, MediBuddy leverages technology to effectively connect patients with healthcare providers, thereby bridging the gap in healthcare accessibility.
DocsApp is an online doctor consultation platform. DocsApp is a mobile platform where people from India can consult a specialist MD Doctors with in 30 minutes in various specialisations through chat or call from the location of their convenience. DocsApp has specialist Doctors in the following specialisations.
Tricog Health
Series B in 2020
Tricog Health is a company that specializes in cardiac diagnostic tools aimed at addressing cardiovascular conditions through real-time identification and accurate analysis. Utilizing medical-grade artificial intelligence, Tricog improves cardiac care by bridging gaps in infrastructure, expertise, and efficiency within healthcare systems. The company offers virtual diagnostic tools and services that empower healthcare providers to make timely and precise diagnoses, ultimately enhancing patient outcomes. Tricog's innovative medical device facilitates real-time reporting and analysis of electrocardiography results without the need for additional hardware, ensuring early detection of potentially life-threatening cardiac events.